How to Fight Pharmaceutical Counterfeiting

Pharmaceutical Packaging How to Fight Pharmaceutical Counterfeiting

17.06.2013Author / Editor: Dr. Jérôme Freissmuth / Dominik Stephan

Counterfeiters are increasingly targeting the pharmaceutical supply chain – a dangerous trend that can have fatal consequences. All supply chain players can contribute to increased safety, from producers of Active Pharmaceutical Ingredients (APIs) to packagers and equipment manufacturers, supported by numerous initiatives and legislative efforts.

Related Vendors

Schubert_CP_gross_rgb (003).jpg (Gerhard Schubert GmbH)

Gerhard Schubert GmbH - Verpackungsmaschinen

AZO GmbH + Co. KG

Glatt Ingenieurtechnik GmbH

Each pharmaceutical pack must be equipped with a batch number and expiry date. In future, a machine readable code such as a data matrix code with a serial number must be additionally printed onto each pack. The serial number at the package level is one of the most important strategies laid down in recent guidance and legislations.
(Picture: Bosch Packaging Technology)

Counterfeit pharmaceuticals are those that have arrived on the market as licensed drugs without having passed through the official channels. In such cases, the counterfeit drugs may contain wrong or any active ingredient or the correct active ingredient in an incorrect quantity.

The bestcase scenario may find a drug becoming ineffective and in the worst case, fatalities may occur if the illegitimately made drugs do not have the desired effect. Counterfeiters not only manufacture imitations of prescription-only drugs, but also over-thecounter (OTC) products, generics, originator products and traditional drugs.

New Distribution Channels

The World Health Organization (WHO) estimates that every second pharmaceutical product purchased via the Internet is counterfeit. Anabolic drugs and potency pills range among the most frequently ordered products. Apart from these so-called lifestyle medicines, more and more prescription drugs like antibiotics and medicines for cancer treatment are sold by online pharmacies. A study conducted by the European Alliance for Safe Medicines (EAASM) found that in 90.3 per cent of all cases, no prescription was required for the online purchase of prescription-only drugs.

More than 50 per cent of medicines purchased from illegal websites concealing their physical address have been found to be counterfeit. But the Internet is not the only channel by which counterfeits enter the market. The pharmaceutical wholesalers too are targeted by counterfeiters. By introducing large quantities of falsified medicines into the legal supply chain, lucrative transactions are made in a very short time. This depends strongly on the geographical area. For example, in most of Europe, the amount of falsified medicine is estimated at approximately one per cent, while the developing world sees figures up to 50 per cent of counterfeit pharmaceuticals.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

Business E-mail

Please enter a valid mailadress.

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Stand vom 23.03.2021

Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.

Consent to the use of data for promotional purposes

I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here

Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.

In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.

Right of revocation

I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://support.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.

(ID:40096810)